G E Crane. Show Affiliations »
Abstract
Mesh: See more » Age FactorsAntiparkinson AgentsCentral Nervous System Diseases/complicationsCentral Nervous System Diseases/drug therapyChlorpromazine/adverse effectsChronic DiseaseDisease SusceptibilityDose-Response Relationship, DrugFemaleHumansMaleMovement Disorders/chemically inducedNeurologic ManifestationsParkinson Disease, Secondary/chemically inducedTime Factors
Substances: See more » Antiparkinson AgentsChlorpromazine
Year: 1974 PMID: 4836206
Source DB: PubMed Journal: Adv Biochem Psychopharmacol ISSN: 0065-2229